Bryan F. Cox's most recent trade in TriSalus Life Sciences Inc was a trade of 15,722 Common Stock done at an average price of $5.2 . Disclosure was reported to the exchange on May 19, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
TriSalus Life Sciences Inc | Bryan F. Cox | Chief of Research | Grant, award, or other acquisition of securities at price $ 5.18 per share. | 19 May 2025 | 15,722 | 124,179 | - | 5.2 | 81,440 | Common Stock |
TriSalus Life Sciences Inc | Bryan F. Cox | Chief of Research | Sale of securities on an exchange or to another person at price $ 5.18 per share. | 19 May 2025 | 4,764 | 119,415 | - | 5.2 | 24,678 | Common Stock |
TriSalus Life Sciences Inc | Bryan F. Cox | CHIEF OF RESEARCH | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 11,450 | 108,457 | - | 0 | Common Stock | |
TriSalus Life Sciences Inc | Bryan F. Cox | CHIEF OF RESEARCH | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 63,750 | 63,750 | - | - | Employee Stock Option (right to buy) | |
TriSalus Life Sciences Inc | Bryan F. Cox | CHIEF OF RESEARCH | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 10,625 | 97,007 | - | 0 | Common Stock | |
TriSalus Life Sciences Inc | Bryan F. Cox | CHIEF SCIENTIFIC & MANUFACT. | Sale of securities on an exchange or to another person at price $ 4.44 per share. | 05 Oct 2024 | 314 | 86,382 | - | 4.4 | 1,394 | Common Stock |
TriSalus Life Sciences Inc | Bryan Cox F. | CHIEF SCIENTIFIC & MANUFACT. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 63,750 | 63,750 | - | - | Employee Stock Option (right to buy) | |
TriSalus Life Sciences Inc | Cox F. Bryan | CHIEF SCIENTIFIC & MANUFACT. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 14,752 | 86,696 | - | 0 | Common Stock | |
TriSalus Life Sciences Inc | Bryan F. Cox | Chief Scientific & Manufact. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2023 | 40,000 | 40,000 | - | - | Employee Stock Option (right to buy) |